This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
price-performance: Archive
Why Hims & Hers Health, Inc. (HIMS) Might be Well Poised for a Surge
by Zacks Equity Research
Hims & Hers Health, Inc. (HIMS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
HIMSNegative Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Why Hillman Solutions Corp. (HLMN) Might be Well Poised for a Surge
by Zacks Equity Research
Hillman Solutions Corp. (HLMN) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
HLMNNegative Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
What Makes Terumo Corp. (TRUMY) a Good Fit for 'Trend Investing'
by Zacks Equity Research
Terumo Corp. (TRUMY) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
TRUMYNegative Net Change
price-performance stock-price-change stock-price-movement
Here's Why Momentum in EyePoint Pharmaceuticals (EYPT) Should Keep going
by Zacks Equity Research
EyePoint Pharmaceuticals (EYPT) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
EYPTPositive Net Change
price-performance stock-price-change stock-price-movement
Erie Indemnity (ERIE) Is a Great Choice for 'Trend' Investors, Here's Why
by Zacks Equity Research
Erie Indemnity (ERIE) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
ERIENegative Net Change
price-performance stock-price-change stock-price-movement
Here's What Could Help Inotiv, Inc. (NOTV) Maintain Its Recent Price Strength
by Zacks Equity Research
Inotiv, Inc. (NOTV) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
NOTVPositive Net Change
price-performance stock-price-change stock-price-movement
Recent Price Trend in Cass (CASS) is Your Friend, Here's Why
by Zacks Equity Research
Cass (CASS) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
CASSNegative Net Change
price-performance stock-price-change stock-price-movement
Will TPG RE Finance Trust (TRTX) Gain on Rising Earnings Estimates?
by Zacks Equity Research
TPG RE Finance Trust (TRTX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
TRTXNegative Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Can DigitalOcean Holdings, Inc. (DOCN) Run Higher on Rising Earnings Estimates?
by Zacks Equity Research
DigitalOcean Holdings, Inc. (DOCN) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
DOCNPositive Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Why SPX Technologies (SPXC) Might be Well Poised for a Surge
by Zacks Equity Research
SPX Technologies (SPXC) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
SPXCNegative Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Why AssetMark Financial (AMK) Might be Well Poised for a Surge
by Zacks Equity Research
AssetMark Financial (AMK) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Here's Why 'Trend' Investors Would Love Betting on Encore Wire (WIRE)
by Zacks Equity Research
Encore Wire (WIRE) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
WIREPositive Net Change
price-performance stock-price-change stock-price-movement
Kiniksa Pharmaceuticals, Ltd. (KNSA) is on the Move, Here's Why the Trend Could be Sustainable
by Zacks Equity Research
Kiniksa Pharmaceuticals, Ltd. (KNSA) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
KNSAPositive Net Change
price-performance stock-price-change stock-price-movement
Here's What Could Help Tourmaline Bio, Inc. (TRML) Maintain Its Recent Price Strength
by Zacks Equity Research
Tourmaline Bio, Inc. (TRML) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
TRMLPositive Net Change
price-performance stock-price-change stock-price-movement
Quad/Graphics (QUAD) Is a Great Choice for 'Trend' Investors, Here's Why
by Zacks Equity Research
If you are looking for stocks that are well positioned to maintain their recent uptrend, Quad/Graphics (QUAD) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
QUADNegative Net Change
price-performance stock-price-change stock-price-movement
Here's Why Momentum in Icon PLC (ICLR) Should Keep going
by Zacks Equity Research
Icon PLC (ICLR) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
ICLRNegative Net Change
price-performance stock-price-change stock-price-movement
Keros Therapeutics, Inc. (KROS) is on the Move, Here's Why the Trend Could be Sustainable
by Zacks Equity Research
Keros Therapeutics, Inc. (KROS) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
KROSPositive Net Change
price-performance stock-price-change stock-price-movement
AxoGen (AXGN) Is a Great Choice for 'Trend' Investors, Here's Why
by Zacks Equity Research
AxoGen (AXGN) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
AXGNPositive Net Change
price-performance stock-price-change stock-price-movement
ICICI Bank Limited (IBN) Is a Great Choice for 'Trend' Investors, Here's Why
by Zacks Equity Research
ICICI Bank Limited (IBN) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
IBNNegative Net Change
price-performance stock-price-change stock-price-movement
Can Olo Inc. (OLO) Run Higher on Rising Earnings Estimates?
by Zacks Equity Research
Olo Inc. (OLO) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
OLONegative Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Earnings Estimates Moving Higher for Synopsys (SNPS): Time to Buy?
by Zacks Equity Research
Synopsys (SNPS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
SNPSNegative Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Here's What Could Help Hackett Group (HCKT) Maintain Its Recent Price Strength
by Zacks Equity Research
Hackett Group (HCKT) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
HCKTNegative Net Change
price-performance stock-price-change stock-price-movement
Here's Why Momentum in Krystal Biotech, Inc. (KRYS) Should Keep going
by Zacks Equity Research
Krystal Biotech, Inc. (KRYS) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
KRYSNegative Net Change
price-performance stock-price-change stock-price-movement
Curtiss-Wright (CW) is on the Move, Here's Why the Trend Could be Sustainable
by Zacks Equity Research
Curtiss-Wright (CW) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
CWNegative Net Change
price-performance stock-price-change stock-price-movement
Can Toll Brothers (TOL) Run Higher on Rising Earnings Estimates?
by Zacks Equity Research
Toll Brothers (TOL) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
TOLNegative Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank